Ebola Outbreak in Uganda Death Toll Reaches 177 Global Health Stocks and Travel Sector Await Impact Attacks on Preah Vihear Temple May Undermine Global Heritage Preservation Efforts Tesla Launches Full SelfDriving Supervised in China After Years of Delays Amid Local EV Competition HFCL Shares Surge 140 in Two Months on Strong Q4 Earnings and Export Order Wins Staten Island Shipyard Explosion Causes Casualties Raises Safety Concerns for Port Operations Bessent Anticipates Substantial Disinflation as Warshs Potential Fed Leadership Looms White Mountains Insurance Group WTM Q2 2025 Earnings EPS Misses Estimates as Investment Gains Moderate RDZN Q1 2026 Earnings Significant EPS Miss Amidst Lack of Revenue Disclosure AVB Q1 2026 Earnings EPS Surpasses Estimates by 81 Amid Stable Multifamily Demand CNTY Q1 2026 Earnings EPS Surpasses Estimate Despite Net Loss Coffee Holding Co Inc JVA Q4 2019 Earnings EPS Misses Estimates by Wide Margin Amid Ongoing Industry Challenges BMY Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Portfolio Strength Chesapeake Utilities CPK Edges Higher Amid Steady Utility Sector Performance Rocky Brands Inc RCKY Holds Near Support as Price Action Remains Cautious ST Bancorp STBA Holds Steady Near Support as Market Awaits Catalyst Atara Biotherapeutics ATRA Faces Selling Pressure Near Key Resistance Zone Anixa Biosciences ANIX Slides 215 as Biotech Sector Headwinds Return CRIS Q1 2026 Earnings WiderThanExpected Loss on No Reported Revenue Stock Rises Despite Miss SBSW Q2 2022 Earnings EPS Misses Estimates Amid Operational Challenges DocGo DCGO Q1 2026 Earnings EPS Misses by 3655 as Stock Rises 479 Central Garden Pet Company CENTA Q1 2026 Earnings Earnings Beat Driven by Operational Discipline Amid Mixed TopLine Signals CDZIP Q1 2026 Earnings NarrowerThanExpected Loss Reflects Cost Discipline Amid Water Resource Development HURN Q1 2026 Earnings EPS Surpasses Estimates by 58 Shares Edge Higher Labours Streeting Challenges Blair Harnessing AI Through Democracy Not Markets Lexeo Therapeutics Q1 2026 Earnings EPS Beat on Lower Operating Costs Definium Therapeutics DFTX Gains on Strength Approaching Key Resistance